Industry News
Biotechnology Industry News
Avistone nabs $200M cancer platform funding drive from leading VCs as it combines with Pearl Biotech
Avistone nabs $200M cancer platform funding drive from leading VCs as it combines with Pearl Biotech badams Tue, 12/07/2021 - 04:13
GlaxoSmithKline, Medicago hit 75% efficacy against delta COVID strain, but omicron muddies waters
GlaxoSmithKline, Medicago hit 75% efficacy against delta COVID strain, but omicron muddies waters badams Mon, 12/06/2021 - 14:55
Apple Tree Partners breaks into UK with biotech Adendra Therapeutics launch, $53M series A raise
Apple Tree Partners breaks into UK with biotech Adendra Therapeutics launch, $53M series A raise elucas Mon, 12/06/2021 - 13:42
Could Viagra prevent and treat Alzheimer’s? Cleveland Clinic team shows its potential
Could Viagra prevent and treat Alzheimer's? Cleveland Clinic team shows its potential arlene.weintraub Mon, 12/06/2021 - 09:57
Biohaven pain spray aces test as C-suite shake-up sees incoming CFO, chief in chairman role
Biohaven pain spray aces test as C-suite shake-up sees incoming CFO, chief in chairman role badams Mon, 12/06/2021 - 09:48
Investors punish Aeglea for missed rare disease secondaries, sending stock spiraling despite primary endpoint success
Investors punish Aeglea for missed rare disease secondaries, sending stock spiraling despite primary endpoint success ntaylor Mon, 12/06/2021 - 08:58
Adicet soars on early responses to gamma delta CAR-T therapy
Adicet soars on early responses to gamma delta CAR-T therapy ntaylor Mon, 12/06/2021 - 08:19
OncoMyx nabs $50M to jump into the clinic with its rabbit pox virus cancer drug
OncoMyx nabs $50M to jump into the clinic with its rabbit pox virus cancer drug badams Mon, 12/06/2021 - 05:07
Genetic variant linked to Amish community could pave way for new heart disease therapies
Genetic variant linked to Amish community could pave way for new heart disease therapies klahucik Sun, 12/05/2021 - 17:48
Gene therapy startup bursts forth from incubation at J&J and F-Prime, graduating with $80M and a Novartis veteran at the helm
Gene therapy startup bursts forth from incubation at J&J and F-Prime, graduating with $80M and a Novartis veteran at the helm ntaylor Fri, 12/03/2021 - 07:24
Little European biotech Sotio nabs a super $316M funding round for its superagonist work
Little European biotech Sotio nabs a super $316M funding round for its superagonist work badams Fri, 12/03/2021 - 05:22
BeyondSpring lurches down as FDA rejects plinabulin, raising questions about lung cancer prospects
BeyondSpring lurches down as FDA rejects plinabulin, raising questions about lung cancer prospects ntaylor Fri, 12/03/2021 - 03:48
Fore fires CEO Malik after SEC insider trading charges during his time as Immunomedics CFO
Fore fires CEO Malik after SEC insider trading charges during his time as Immunomedics CFO klahucik Thu, 12/02/2021 - 12:52
Alpha challenger: Novartis pays UCB $150M to join Roche, AstraZeneca in Parkinson’s race
Alpha challenger: Novartis pays UCB $150M to join Roche, AstraZeneca in Parkinson's race ntaylor Thu, 12/02/2021 - 07:48
GlaxoSmithKline, University of Oxford join forces in $40M digital deep dive into neuro
GlaxoSmithKline, University of Oxford join forces in $40M digital deep dive into neuro badams Thu, 12/02/2021 - 05:40
Tune Therapeutics’ epigenetic platform resonates with investors as it snags $40M in financing
Tune Therapeutics' epigenetic platform resonates with investors as it snags $40M in financing klahucik Wed, 12/01/2021 - 12:58
Aclaris’ experimental rheumatoid arthritis drug bolsters chemo in pancreatic cancer models
Aclaris' experimental rheumatoid arthritis drug bolsters chemo in pancreatic cancer models arlene.weintraub Wed, 12/01/2021 - 10:54
Astellas becomes latest Dyno gene therapy partner with $1.6B biobucks pact to join Roche, Novartis, Sarepta
Astellas becomes latest Dyno gene therapy partner with $1.6B biobucks pact to join Roche, Novartis, Sarepta klahucik Wed, 12/01/2021 - 09:58
Vertex once again talks up a tiny trial with positive read-throughs, this time for a genetically driven approach to kidney disease
Vertex once again talks up a tiny trial with positive read-throughs, this time for a genetically driven approach to kidney disease badams Wed, 12/01/2021 - 08:08
J&J cell therapy head exits to take up post at fledgling biotech
J&J cell therapy head exits to take up post at fledgling biotech ntaylor Wed, 12/01/2021 - 07:43